ACTAVIS LABS FL INC FDA Approval ANDA 091093

ANDA 091093

ACTAVIS LABS FL INC

FDA Drug Application

Application #091093

Documents

Review2012-06-22
Letter2011-09-12

Application Sponsors

ANDA 091093ACTAVIS LABS FL INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET, EXTENDED RELEASE;ORAL500MG0LEVETIRACETAMLEVETIRACETAM
002TABLET, EXTENDED RELEASE;ORAL750MG0LEVETIRACETAMLEVETIRACETAM

FDA Submissions

ORIG1AP2011-09-12
LABELING; LabelingSUPPL3AP2014-09-26STANDARD

Submissions Property Types

ORIG1Null15
SUPPL3Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91093
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"500MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"750MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LEVETIRACETAM","submission":"LEVETIRACETAM","actionType":"500MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVETIRACETAM","submission":"LEVETIRACETAM","actionType":"750MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.